Buy hGH Fragment 176-191 6mg – Peptide Science

hGH Fragment 176-191 6mg Overview

hGH Fragment 176-191 6mg from Peptide Science is the synthetic 16-amino-acid C-terminal fragment of human growth hormone (residues 176 to 191), supplied as a lyophilised vial for in-vitro lipolytic-pathway and preclinical adipose-tissue research. The fragment corresponds to the lipolytic domain of the parent 191-residue hGH protein, isolated from the somatotropic activity by truncation.

Compound Class and Mechanism

hGH Fragment 176-191 is closely related to AOD-9604 (which adds an N-terminal tyrosine to the same core 15 residues for stability). Preclinical research has characterised the fragment for lipolytic activity in cultured adipocytes via beta-3 adrenergic-receptor-adjacent pathways, without measurable IGF-1 or GH-receptor signalling. The compound is studied as a research tool for separating the lipolytic from the somatotropic actions of the parent hGH protein. Browse the broader metabolic peptide range.

Specifications

For the stability-enhanced N-terminal-tyrosine variant, see AOD-9604 Peptide 6mg.

Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in peptide-research literature.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation against the theoretical molecular weight. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease, including obesity or type 2 diabetes. Has not been evaluated by the U.S. Food and Drug Administration. Branded therapeutic GLP-1 medicines (Ozempic, Wegovy, Mounjaro, Zepbound) are prescription-only and are not the same as research-grade compounds. Purchasers acknowledge they are qualified researchers age 21 or older.